ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,368.80
0.28%
Dow Jones
39,069.59
0.01%
Brent Oil
83.075
0.28%
Bitcoin
68,518.99
-1.26%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Cryptocurrencies
  4. COIN
  5. (Cryptocurrency:INFXUSD)

  6. (Cryptocurrency:INFXUSD) News

INFXUSD

(INFXUSD)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/28/20247:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MOBBWMobilicom Ltd
05/28/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:KXINKaixin Holdings
05/28/20247:00AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:GROYGold Royalty Corp
05/28/20247:00AMEdgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:GILTGilat Satellite Networks Ltd
05/28/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOCNWBlue Ocean Acquisition Corporation
05/28/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPAKGamer Pakistan Inc
05/28/20247:00AMGlobeNewswire Inc.Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate and Favorable Safety Profile in 1L r/m HNSCCNASDAQ:MRUSMerus NV
05/28/20247:00AMBusiness WireAsahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company
05/28/20247:00AMGlobeNewswire Inc.Creative Realities Closes on New Revolving Credit FacilityNASDAQ:CREXCreative Realities Inc
05/28/20247:00AMGlobeNewswire Inc.Forsys Reports Interim Drilling Results at NorasaTSX:FSYForsys Metals Corp
05/28/20247:00AMBusiness WirePre-Owned Business Jets Selling 45% Faster Since 2019, Reveals Annual Jetcraft Market Forecast
05/28/20247:00AMGlobeNewswire Inc.Nevada Exploration Forms Advisory Board and Appoints Former Uranerz Uranium ProfessionalsTSXV:NGENevada Exploration Inc
05/28/20247:00AMBusiness WireMindMed to Participate in June ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
05/28/20247:00AMGlobeNewswire Inc.Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical OfficerNASDAQ:NRIXNurix Therapeutics Inc
05/28/20247:00AMGlobeNewswire Inc.FactSet Schedules Third Quarter 2024 Earnings CallNYSE:FDSFactSet Research Systems Inc
05/28/20247:00AMGlobeNewswire Inc.Les données intermédiaires du pétosemtamab de Merus en association avec le pembrolizumab démontrent un taux de réponse important et un profil d’innocuité favorable dans le traitement de première ligne du CETC r/mTG:2GHMerus NV
05/28/20247:00AMBusiness WireCartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
05/28/20247:00AMGlobeNewswire Inc.West Red Lake Gold Announces Listing of WarrantsTSXV:WRLGWest Red Lake Gold Mines Ltd
05/28/20247:00AMGlobeNewswire Inc.Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals
05/28/20247:00AMGlobeNewswire Inc.Agios Announces $905 Million Purchase Agreement for Vorasidenib RoyaltyNASDAQ:AGIOAgios Pharmaceuticals Inc
05/28/20247:00AMBusiness WireStevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco MoroNYSE:STVNStevanato Group SpA
05/28/20247:00AMBusiness WireMarketing Architects Unveils ‘Smart Targeting’ to Improve CTV Performance
05/28/20247:00AMBusiness WireAtlasClear Holdings, Inc. Announces First Quarter 2024 Financial ResultsAMEX:ATCHAtlasClear Holdings Inc
05/28/20247:00AMGlobeNewswire Inc.9thCO Crafts Next.js-Powered Online Marketplace for Travel Startup RollDeep
05/28/20247:00AMGlobeNewswire Inc.Foghorn Therapeutics to Participate in Upcoming Investor Conferences in JuneNASDAQ:FHTXFoghorn Therapeutics Inc
05/28/20247:00AMGlobeNewswire Inc.Ocean Power Technologies Completes Operation with Multiple Unmanned Surface Vehicles for US GovernmentAMEX:OPTTOcean Power Technologies Inc
05/28/20247:00AMBusiness WireMontrose Environmental Group Leadership, 3M Chief Technology Officer Discuss Successful Advancements for Removal of “Forever Chemicals” from WaterNYSE:MEGMontrose Environmental Group Inc
05/28/20247:00AMGlobeNewswire Inc.Major Drilling to Release Fourth Quarter and Fiscal 2024 ResultsTSX:MDIMajor Drilling Group International Inc
05/28/20247:00AMGlobeNewswire Inc.Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals
05/28/20247:00AMGlobeNewswire Inc.Forsys Reports Interim Drilling Results at NorasaTG:F2TForsys Metals Corp

Your Recent History

USOTC
ACRL
Atacama Resources (PK)
USOTC
PWDY
Powerdyne (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
DJT
Trump Media and Technology
USOTC
CLNV
Clean Vision (QB)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NYSE
GME
GameStop
USOTC
PSRU
Valiant Eagle (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
SPZI
Spooz (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KEGS
1812 Brewing (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved